Literature DB >> 6313192

High-dose cyclophosphamide (7 g/m2) with or without autologous bone marrow rescue after conventional chemotherapy in the treatment of patients with small cell lung cancer.

I E Smith, B D Evans, S J Harland.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1983        PMID： 6313192     DOI： 10.1016/s0305-7372(83)80011-5

Source DB:  PubMed          Journal:  Cancer Treat Rev        ISSN： 0305-7372            Impact factor:   12.111


× No keyword cloud information.
  3 in total

1.  Prevention of cyclophosphamide-induced urotoxicity by reduced glutathione and its effect on acute toxicity and antitumor activity of the alkylating agent.

Authors:  O Tofanetti; E Cavalletti; A Besati; G Pratesi; G Pezzoni; F Zunino
Journal:  Cancer Chemother Pharmacol       Date:  1985       Impact factor: 3.333

2.  High-dose cyclophosphamide with autologous bone marrow rescue after conventional chemotherapy in the treatment of small cell lung carcinoma.

Authors:  I E Smith; B D Evans; S J Harland; B A Robinson; J R Yarnold; J G Glees; H T Ford
Journal:  Cancer Chemother Pharmacol       Date:  1985       Impact factor: 3.333

3.  A phase I trial of continuous-infusion cyclophosphamide in refractory cancer patients.

Authors:  J P Eder; A D Elias; L Ayash; C A Wheeler; T C Shea; L E Schnipper; E Frei; K H Antman
Journal:  Cancer Chemother Pharmacol       Date:  1991       Impact factor: 3.333
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.